治療用低体温療法システムの市場：製品、用途、エンドユーザー別-2025年～2030年の世界予測

治療用低体温療法システム市場は、2023年に3億389万米ドルと評価され、2024年には3億2,331万米ドルに達すると予測され、CAGR 6.68%で成長し、2030年には4億7,790万米ドルに達すると予測されています。

治療用低体温療法システムは、主に心停止後の虚血性損傷、外傷性脳損傷、新生児窒息のリスクを軽減するために、体温を下げるために使用される特殊な医療機器です。これらのシステムには、冷却毛布、ヘルメット、高度体温管理装置などがあります。これらのシステムの必要性は、神経学的損傷を最小限に抑え、患者の転帰を改善する能力から生じており、世界中の集中治療室で支持を集めています。これらのシステムは、救急医療、外科手術、術後の回復などにおいて重要な用途を担っており、病院、専門クリニック、研究機関における最終用途の広範な範囲を反映しています。

市場力学は、心血管障害の有病率の増加、ヘルスケア提供者の意識の向上、技術の進歩に大きく影響され、より洗練されたポータブルシステムへの需要を押し上げています。世界人口の高齢化は潜在的なユーザー層をさらに拡大し、より広範な市場機会を生み出しています。世界各国の政府もヘルスケア・インフラの改善に投資しており、潜在的な資金調達手段を提供しています。しかし、設置やメンテナンスにかかるコストの高さ、地域間で標準化されたプロトコルの欠如、不適切な使用による合併症の可能性といった課題が、市場の成長を阻害しています。さらに、規制上のハードルや医療従事者の専門的なトレーニングの必要性が大きな障壁となっています。

新たなビジネスチャンスを生かすには、機器の小型化、携帯性の向上、正確な温度制御のためのAIとの統合といった技術革新が重要な分野となります。さらに、R&Dイニシアチブのためのパートナーシップを模索し、ヘルスケア専門家向けの教育プログラムに注力することで、市場への浸透を高めることができます。また、動物用治療的低体温療法のようなニッチ分野も未開拓の可能性を秘めています。こうした成長の道筋があるにもかかわらず、市場関係者は製品の有効性、安全性、費用対効果を強調する一方で、使用法を合理化するために統一された臨床ガイドラインを提唱することで、課題を乗り切らなければならないです。市場情勢はダイナミックであるため、規制状況の変化に適応し、デジタルヘルスの動向を取り入れることが、事業の持続的成長には不可欠です。

市場力学：急速に進化する治療用低体温療法システム市場の主要市場インサイトを公開

治療用低体温療法システム市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心停止および神経障害の有病率の上昇
  • 乳幼児の新生児医療の採用拡大
  • 低侵襲の冷却方法に対する需要の増加
• 市場抑制要因
  • 治療用低体温療法システムに関連する高コスト
• 市場機会
  • 治療用低体温療法システムの移植時の臓器保存への応用拡大
  • 高度な治療法に対する意識の高まりによる医療費の増加
• 市場の課題
  • 熟練したヘルスケア専門家の不足

ポーターのファイブフォース：治療用低体温療法システム市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：治療用低体温療法システム市場における外部からの影響の把握

外部マクロ環境要因は、治療用低体温療法システム市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析治療用低体温療法システム市場における競合情勢の把握

治療用低体温療法システム市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス治療用低体温療法システム市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、治療用低体温療法システム市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨治療用低体温療法システム市場における成功への道筋を描く

治療用低体温療法システム市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心停止と神経疾患の罹患率の上昇
    • 乳児における新生児ケアの導入増加
    • 低侵襲冷却法の需要増加
  • 抑制要因
    • 治療用低体温療法システムに関連する高コスト
  • 機会
    • 移植時の臓器保存への治療用低体温療法システムの応用拡大
    • 先進的な治療法に対する意識の高まりとともにヘルスケア費が増加
  • 課題
    • 熟練したヘルスケア専門家の不足
• 市場セグメンテーション分析
  • 製品：低酸素性虚血性脳症の治療にクールキャップが好まれる傾向
  • 応用：心臓病学における治療用低体温療法システムの応用の拡大
  • エンドユーザー：病院における治療用低体温療法システムの需要増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 治療用低体温療法システムの市場：製品別

• クールキャップ
• 冷却カテーテル
• 冷却装置

第7章 治療用低体温療法システムの市場：用途別

• 心臓病学
• 新生児ケア
• 神経学

第8章 治療用低体温療法システムの市場：エンドユーザー別

• 外来手術センター
• 病院

第9章 南北アメリカの治療用低体温療法システムの市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋の治療用低体温療法システムの市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの治療用低体温療法システムの市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
  • PLUSSとロドナイト・パートナーシップが、発展途上国におけるミラクレイドル機器の提供に向けて提携
  • ノースカロライナ州のスタートアップNovocorがシリーズAラウンドで約100万米ドルを調達
  • BrainCoolがEUで特許を取得
• 戦略分析と提言

企業一覧

• Aspen Systems
• Becton, Dickinson, and Company
• Belmont Instrument, LLC
• Cryothermic Systems Incorporated
• Dignitana AB
• EM-MED Sp. z o.o.
• Gentherm GmbH
• Getinge AB
• International Biomedical Ltd.
• Koninklijke Philips N.V.
• Life Recovery Systems
• Paxman Coolers Limited
• pfm medical hico gmbh
• Phoenix Medical Systems
• Pluss Advanced Technologies Pvt. Ltd.
• Shenzhen Comen Medical Instruments Co., Ltd.
• Stryker Corporation
• VNG Medical Innovation System Pvt Ltd.
• Wishcaps
• ZOLL Medical Corporation

LIST OF FIGURES

• FIGURE 1. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET RESEARCH PROCESS
• FIGURE 2. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET DYNAMICS
• TABLE 7. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOL CAPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COOLING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEONATAL CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. CANADA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CHINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. INDIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ITALY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. POLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. QATAR THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. THERAPEUTIC HYPOTHERMIA SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2023

The Therapeutic Hypothermia Systems Market was valued at USD 303.89 million in 2023, expected to reach USD 323.31 million in 2024, and is projected to grow at a CAGR of 6.68%, to USD 477.90 million by 2030.

Therapeutic Hypothermia Systems are specialized medical devices used to lower the body's temperature, primarily to reduce the risk of ischemic injuries post-cardiac arrest, traumatic brain injuries, and in neonatal asphyxia cases. These systems include cooling blankets, helmets, and advanced temperature management units. The necessity for these systems arises from their capacity to minimize neurological damage and improve patient outcomes, which is gaining traction in intensive care units worldwide. They serve significant applications in emergency care, surgical procedures, and post-operative recovery, reflecting a broad scope for end-use in hospitals, specialty clinics, and research institutions.

Market dynamics are heavily influenced by a growing prevalence of cardiovascular disorders, increased awareness among healthcare providers, and technological advancements, pushing the demand for more sophisticated and portable systems. The aging global population further expands the potential user base, thus creating broader market opportunities. Governments worldwide are also investing in improved healthcare infrastructure, offering potential funding avenues. However, challenges such as high costs of installation and maintenance, lack of standardized protocols across regions, and possible complications from improper usage impede market growth. Additionally, regulatory hurdles and the need for specialized training for medical personnel pose significant barriers.

To capitalize on emerging opportunities, innovations in device miniaturization, enhanced portability, and integration with AI for precise temperature control are critical areas. Furthermore, exploring partnerships for R&D initiatives and focusing on education programs for healthcare professionals can enhance market penetration. Niche segments like veterinary therapeutic hypothermia also present untapped potential. Despite these growth avenues, market players must navigate challenges by emphasizing product efficacy, safety, and cost-effectiveness, while advocating for uniform clinical guidelines to streamline usage. As the market landscape is dynamic, adapting to regulatory changes and embracing digital health trends will be essential for sustained business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Therapeutic Hypothermia Systems Market

The Therapeutic Hypothermia Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of cardiac arrest and neurological disorders
  • Growing adoption of neonatal care in infants
  • Increasing demand for minimally invasive cooling methods
• Market Restraints
  • High cost associated with therapeutic hypothermia systems
• Market Opportunities
  • Expanding the application of therapeutic hypothermia systems for organ preservation during transplantation
  • Increasing healthcare expenditures with rising awareness about advanced treatment options
• Market Challenges
  • Lack of skilled healthcare professionals

Porter's Five Forces: A Strategic Tool for Navigating the Therapeutic Hypothermia Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Therapeutic Hypothermia Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Therapeutic Hypothermia Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Therapeutic Hypothermia Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Therapeutic Hypothermia Systems Market

A detailed market share analysis in the Therapeutic Hypothermia Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Therapeutic Hypothermia Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Therapeutic Hypothermia Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Therapeutic Hypothermia Systems Market

A strategic analysis of the Therapeutic Hypothermia Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Therapeutic Hypothermia Systems Market, highlighting leading vendors and their innovative profiles. These include Aspen Systems, Becton, Dickinson, and Company, Belmont Instrument, LLC, Cryothermic Systems Incorporated, Dignitana AB, EM-MED Sp. z o.o., Gentherm GmbH, Getinge AB, International Biomedical Ltd., Koninklijke Philips N.V., Life Recovery Systems, Paxman Coolers Limited, pfm medical hico gmbh, Phoenix Medical Systems, Pluss Advanced Technologies Pvt. Ltd., Shenzhen Comen Medical Instruments Co., Ltd., Stryker Corporation, VNG Medical Innovation System Pvt Ltd., Wishcaps, and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Therapeutic Hypothermia Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Cool Caps, Cooling Catheters, and Cooling Devices.
• Based on Application, market is studied across Cardiology, Neonatal Care, and Neurology.
• Based on End-user, market is studied across Ambulatory Surgical Centers and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of cardiac arrest and neurological disorders
    • 5.1.1.2. Growing adoption of neonatal care in infants
    • 5.1.1.3. Increasing demand for minimally invasive cooling methods
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with therapeutic hypothermia systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Expanding the application of therapeutic hypothermia systems for organ preservation during transplantation
    • 5.1.3.2. Increasing healthcare expenditures with rising awareness about advanced treatment options
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of skilled healthcare professionals
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Increasing preference for cool caps to treat hypoxic-ischemic encephalopathy
  • 5.2.2. Application: Expanding application of therapeutic hypothermia systems in cardiology
  • 5.2.3. End-user: Growing demand for therapeutic hypothermia systems among hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Therapeutic Hypothermia Systems Market, by Product

• 6.1. Introduction
• 6.2. Cool Caps
• 6.3. Cooling Catheters
• 6.4. Cooling Devices

7. Therapeutic Hypothermia Systems Market, by Application

• 7.1. Introduction
• 7.2. Cardiology
• 7.3. Neonatal Care
• 7.4. Neurology

8. Therapeutic Hypothermia Systems Market, by End-user

• 8.1. Introduction
• 8.2. Ambulatory Surgical Centers
• 8.3. Hospitals

9. Americas Therapeutic Hypothermia Systems Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Therapeutic Hypothermia Systems Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Therapeutic Hypothermia Systems Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. PLUSS, The Rodnight Partnership Team Up on MiraCradle Device Availability in Developing Nations
  • 12.3.2. NC State Startup Novocor Raises Nearly USD 1M in Series A Round
  • 12.3.3. BrainCool Received Patent Approval in the EU
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Aspen Systems
• 2. Becton, Dickinson, and Company
• 3. Belmont Instrument, LLC
• 4. Cryothermic Systems Incorporated
• 5. Dignitana AB
• 6. EM-MED Sp. z o.o.
• 7. Gentherm GmbH
• 8. Getinge AB
• 9. International Biomedical Ltd.
• 10. Koninklijke Philips N.V.
• 11. Life Recovery Systems
• 12. Paxman Coolers Limited
• 13. pfm medical hico gmbh
• 14. Phoenix Medical Systems
• 15. Pluss Advanced Technologies Pvt. Ltd.
• 16. Shenzhen Comen Medical Instruments Co., Ltd.
• 17. Stryker Corporation
• 18. VNG Medical Innovation System Pvt Ltd.
• 19. Wishcaps
• 20. ZOLL Medical Corporation